Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice.
about
Novel mechanism for mesenchymal stem cells in attenuating peritoneal adhesion: accumulating in the lung and secreting tumor necrosis factor α-stimulating gene-6Adult stem cells as a tool for kidney regenerationSafety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant RecipientsMesenchymal stem cells as a therapeutic approach to glomerular diseases: benefits and risksRegenerative medicine for the kidney: renotropic factors, renal stem/progenitor cells, and stem cell therapyCell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysisProgenitor-like cells derived from mouse kidney protect against renal fibrosis in a remnant kidney model via decreased endothelial mesenchymal transition.Mesenchymal stem cells attenuate peritoneal injury through secretion of TSG-6Paracrine mechanisms in adult stem cell signaling and therapyStem cell therapies benefit Alport syndrome.Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.Rapid deterioration of preexisting renal insufficiency after autologous mesenchymal stem cell therapy.Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation.Searching for a treatment for Alport syndrome using mouse modelsDecompression of inflammatory edema along with endothelial cell therapy expedites regeneration after renal ischemia-reperfusion injury.Transplantation of mesenchymal stem cells promotes tissue regeneration in a glaucoma model through laser-induced paracrine factor secretion and progenitor cell recruitment.Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipientsHuman bone marrow-derived mesenchymal stem cells.Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis.Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potentialAutologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injuryConditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation.Epidermal growth factor attenuates tubular necrosis following mercuric chloride damage by regeneration of indigenous, not bone marrow-derived cellsAlphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse.Systematic implantation of dedifferentiated fat cells ameliorated monoclonal antibody 1-22-3-induced glomerulonephritis by immunosuppression with increases in TNF-stimulated gene 6.Injection of amniotic fluid stem cells delays progression of renal fibrosis.Mesenchymal stromal cells in renal ischemia/reperfusion injury.Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative.The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease.Tracking and Therapeutic Value of Human Adipose Tissue-derived Mesenchymal Stem Cell Transplantation in Reducing Venous Neointimal Hyperplasia Associated with Arteriovenous Fistula.Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study.Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology.Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosisSafety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies.Forty-eight hours of unloading and 24 h of reloading lead to changes in global gene expression patterns related to ubiquitination and oxidative stress in humans.Pattern-recognition receptor signaling regulator mRNA expression in humans and mice, and in transient inflammation or progressive fibrosisCellular origins of type IV collagen networks in developing glomeruli.Possible mechanisms of kidney repair.Repeated systemic administration of human adipose-derived stem cells attenuates overt diabetic nephropathy in rats
P2860
Q21999280-1D717A01-1C9B-4614-9554-FB7479FDABF0Q26770750-B7676DE0-48A0-4B05-8BD0-221C2D5000B1Q26799916-6087EE44-5B9B-469E-8827-8EE8AA0B05D7Q26827457-FDDD54BD-A0B4-4535-BA21-C33EB8F4E808Q26865171-D44192A4-9067-4DA3-B294-8C1FF7441D9FQ26866578-0C4E49CC-4C62-4515-8B86-570EDF99796DQ27322429-B6251898-1F38-413E-9B33-7CBD53E62D2EQ28566510-B1F6BC98-12D5-4EB7-A75B-F6984282B8A5Q29620571-05D79A29-CEB3-4E53-BD06-1C5FB5F12265Q33561731-23970BB0-74A5-4BAA-9B86-DF8E52B39033Q33818431-56694C5F-B3D7-4FD1-A5C8-BC35EB7AA022Q33853514-55D69219-39EA-405F-AC44-B8758365B86BQ34289498-BCB09D66-7282-4445-B50D-30C604ACB912Q34453272-F89D3736-29CF-4BBF-9432-C29AF04CC4E3Q34467711-BFD95AFC-2B3B-4FA2-8440-8EB81F141ADBQ34621134-43E1B0A7-26C7-40A0-B627-4F4B70A24044Q34753440-E39CD9AE-857F-40E2-B437-E59EB5460C2BQ34803950-46A2DE2D-88A6-4E72-B4D5-B6C32349E6D9Q35124912-219CD95B-38B0-4137-93AA-8BB26BE2B968Q35130910-23C0F611-6423-446B-A136-B1484FDD5006Q35304596-7A233EC3-4273-45A7-A647-08643D7CD08BQ35370283-BEDE585E-5CB0-426F-B556-AD45096D6FE7Q35531378-30952BCB-9B8B-4F9D-97D9-3699C5869B6EQ35570438-D909FA77-3870-43C0-95A2-9ACBE863E2C1Q35683498-8940EB0B-F944-43A2-9F2D-3BB7372AC43FQ35853316-67D633C9-B3DC-4DE4-965A-33898BD13729Q36070565-B6C7294D-BDA6-44C3-BA61-5EB98E2CB4D0Q36420940-FFA52C16-2600-488F-B173-A51D15D2A3FDQ36510083-D6F094C9-0528-4F69-AA48-7630FD376304Q36734065-A2729A62-8F50-4DD6-BCEC-9C0D43EE8CE0Q36813588-9E7B252C-813C-430B-8CB5-BE5946D896B0Q36861751-DD39BE7B-C5FD-4E61-91B7-F09383135763Q36920724-4527DDDD-17E6-4B07-89CA-246B2BA1E1A2Q36961044-A2CF4CA6-57AE-4E72-ABD7-4DD2869A7A03Q36998733-2B519CA0-AAE4-4CE7-8135-7BF3548E8554Q37174300-4AC916FE-78D1-4909-BE90-21C62E535CE8Q37225102-E90D99F0-2F3E-4B46-87AB-3BBDEBCC7A01Q37259286-F6028863-9CA9-441A-A837-D2331BBB814BQ37265077-FE618B1A-8653-452C-B0D5-327E1B72AF88Q37377889-EF8AE0CD-D3EA-4C5A-BE52-5BF07A40DD75
P2860
Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Multipotent mesenchymal stem c ...... in collagen4A3-deficient mice.
@en
Multipotent mesenchymal stem c ...... in collagen4A3-deficient mice.
@nl
type
label
Multipotent mesenchymal stem c ...... in collagen4A3-deficient mice.
@en
Multipotent mesenchymal stem c ...... in collagen4A3-deficient mice.
@nl
prefLabel
Multipotent mesenchymal stem c ...... in collagen4A3-deficient mice.
@en
Multipotent mesenchymal stem c ...... in collagen4A3-deficient mice.
@nl
P2093
P50
P356
P1433
P1476
Multipotent mesenchymal stem c ...... in collagen4A3-deficient mice
@en
P2093
Buchstaller A
Ninichuk V
Radomska E
Schlöndorff D
P2888
P304
P356
10.1038/SJ.KI.5001521
P407
P577
2006-05-24T00:00:00Z